百令胶囊联合化疗治疗肺癌疗效观察及对肿瘤标志物影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R734.2

基金项目:


Observation on Curative Effect of Bailing Capsules Combined with Chemotherapy for Lung Cancer and Its Effect on Tumor Markers
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察百令胶囊联合化疗治疗肺癌的临床疗效及对肿瘤标志物的影响。方法:选取肺癌患者123 例,随机分为对照组62 例和治疗组61 例。对照组给予常规化疗,治疗组在对照组的基础上联合百令胶囊治疗。21 d 为1 个疗程,共治疗4 个疗程。比较分析2 组临床疗效,治疗前后血清肿瘤标志物神经元特异性烯醇化酶(NSE)、糖类抗原19-9(CA19-9)、癌胚抗原(CEA) 水平变化,治疗前后免疫功能(免疫球蛋白IgA、IgG、IgM)、生活质量(QOL) 评分、卡氏功能状态(KPS) 评分情况。结果:治疗组获益率、客观缓解率分别为95.1%、93.4%,对照组分别为85.5%、75.8%,2 组比较,差异均有统计学意义(P<0.05)。治疗前,2 组NSE、CA19-9、CEA 水平比较,差异无统计学意义(P>0.05);治疗后,2 组NSE、CA19-9、CEA水平均治疗前降低(P<0.05),且治疗组NSE、CA199、CEA 水平低于对照组(P<0.05)。治疗前,2 组IgA、IgG、IgM 水平比较,差异无统计学意义(P>0.05);治疗后,2 组IgA、IgG、IgM 水平较治疗前升高(P<0.05),且治疗组IgA、IgG、IgM 水平高于对照组(P<0.05)。治疗前,2 组QOL、KPS 评分比较,差异无统计学意义(P>0.05);治疗后,2 组QOL、KPS 评分均较治疗前升高(P<0.05),且治疗组QOL、KPS 评分高于对照组(P<0.05)。结论:百令胶囊联合化疗治疗肺癌,可提高临床疗效,提高患QOL、KPS 评分及免疫功能,降低肿瘤标志物水平。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Bailing capsules combined with chemotherapy for lung cancer and its effect on tumor markers. Methods:A total of 123 cases of patients with lung cancer were selected and randomly divided into the control group and the treatment group, 62 and 61 cases in each group respectively. The control group was given routine chemotherapy. The treatment group was treated with Bailing capsules and routine chemotherapy. There were four treatment courses,21 days being one course. The clinical effect was compared and analyzed in the two groups. Before and after treatment,the changes in levels of tumor markers neuron specific enolase(NSE),carbohydrate antigen 19-9(CA19-9), and carcinoembryonic antigen(CEA) , as well as scores of immune function(immunoglobulin IgA , IgG, IgM), quality of life(QOL),and Karnofsky Functional Status(KPS) were compared and analyzed in the two groups. Results:The benefit rate and objective remission rate were 95.1% and 93.4% in the treatment group respectively, while those in the control group were 85.5% and 75.8% respectively, differences being significant(P<0.05). Before treatment, there was no significant difference being found in the comparison of levels of NSE, CA19- 9, and CEA between the two groups(P>0.05). After treatment, levels of NSE, CA19- 9, and CEA in the two groups were decreased when compared with those before treatment(P<0.05),and the three levels in the treatment group were lower than those in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of levels of IgA,IgG,and IgM between the two groups(P>0.05). After treatment,levels of IgA,IgG,and IgM in the two groups were increased when compared with those before treatment(P<0.05),and the three levels in the treatment group were higher than those in the control group(P< 0.05). Before treatment, there was no significant difference being found in the comparison of scores of QOL and KPS between the two groups(P>0.05). After treatment, scores of QOL and KPS in the two groups were increased when compared with those before treatment(P<0.05),and the two scores in the treatment group were higher than those in the control group(P<0.05). Conclusion: The therapy of Bailing capsules combined with chemotherapy for the lung cancer can improve clinical effect,enhance immune function as well as scores of QOL and KPS,and reduce levels of tumor markers.

    参考文献
    相似文献
    引证文献
引用本文

沈剑,霍仁,张正辉.百令胶囊联合化疗治疗肺癌疗效观察及对肿瘤标志物影响[J].新中医,2021,53(18):123-126

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-09-24
  • 出版日期: